Latest & greatest articles for mometasone

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mometasone or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mometasone and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mometasone

1. Mometasone

Mometasone Top results for mometasone - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2 (...) ) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for mometasone The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms

2018 Trip Latest and Greatest

2. Montelukast versus inhaled mometasone for treatment of otitis media with effusion in children: A randomized controlled trial (PubMed)

Montelukast versus inhaled mometasone for treatment of otitis media with effusion in children: A randomized controlled trial Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate (...) in this issue.To compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.This randomized controlled trial was done on 2- to 6-year-old children attending Koodakan Hospital in Bandar Abbas, southern Iran, in 2014. Patients were divided into three groups of montelukast, mometasone, and control group. Audiometry was done for all patients at baseline and four weeks after treatment. Patients were

Full Text available with Trip Pro

2017 Electronic physician

3. Mometasone Furoate (Asmanex Twisthaler) for asthma. It is inhaled, but does not aspire...for something more

Mometasone Furoate (Asmanex Twisthaler) for asthma. It is inhaled, but does not aspire...for something more 2015. DAR No 2: Mometasone Furoate. Asmanex Twisthaler® for asthma management - navarra.es Castellano | Euskara | Français | English Use the search tool! Search engine : : : : : : DAR No 2: Mometasone Furoate. Asmanex Twisthaler® for asthma management DAR No 2: Mometasone Furoate. Asmanex Twisthaler® for asthma management Content tools Share it It is inhaled, but does not aspire (...) ...for something more Mometasone furoate is an inhaled glucocorticoid indicated in the maintenance treatment of persistent asthma. No advantage has been shown in terms of relevant clinical outcomes with respect to other inhaled corticosteroids. The profile of adverse effects and the administration regimen of mometasone are similar to that of other inhaled corticoids. Enviar comentario You can send us a comment or suggestion and we will respond to most frequently asked questions Competing interests (complete

2015 Drug and Therapeutics Bulletin of Navarre (Spain)

4. Asmanex HFA (mometasone furoate) Inhalation Aerosol

Asmanex HFA (mometasone furoate) Inhalation Aerosol Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - Asmanex HFA (mometasone furoate) Inhalation Aerosol Company: Merck Sharp & Dohme Corp. Application No.: 205641 Approval Date: 4/25/2014 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF

2014 FDA - Drug Approval Package

5. Dulera (mometasone furoate and formoterol fumarate) Inhalation Aerosol

Dulera (mometasone furoate and formoterol fumarate) Inhalation Aerosol Drug Approval Package: Dulera (mometasone furoate and formoterol fumarate) NDA #022518 Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - Dulera (mometasone furoate and formoterol fumarate) Inhalation Aerosol 100/5 and 200/5 micrograms Company: Schering Corporation Application No.: 022518 Approval Date: 06/22/2010 Persons with disabilities having problems accessing the PDF files below

2010 FDA - Drug Approval Package

6. Mometasone furoate nasal spray was more effective for symptom relief of acute rhinosinusitis than amoxicillin or placebo

Mometasone furoate nasal spray was more effective for symptom relief of acute rhinosinusitis than amoxicillin or placebo Mometasone furoate nasal spray was more effective for symptom relief of acute rhinosinusitis than amoxicillin or placebo | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using (...) your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Mometasone furoate nasal spray was more effective for symptom relief of acute rhinosinusitis than amoxicillin or placebo Article Text

2007 Evidence-Based Medicine (Requires free registration)